Chinova Bioworks’ $6 Million Series A Financing Round

Osler, Hoskin & Harcourt LLP advised Chinova Bioworks on the round.

On June 22, 2022, Chinova Bioworks announced it had closed its $6 million Series A financing round co-led by DSM Venturing and Rhapsody Venture Partners with participation from Rich Products. This financing will allow Chinova Bioworks to continue building its team, launch new products and expand its production capabilities on Prince Edward Island.

Chinova Bioworks is a Canadian-based company that addresses the growing consumer demand for healthy, natural, clean-label ingredients. Chinova Bioworks is developing a natural and effective antimicrobial mushroom chitosan fiber with broad spectrum protection to enhance the shelf-life of clean label foods, beverages and cosmetics.

The Osler team comprised of Chad Bayne (Picture), Jennifer Humphrey and Janice To (Emerging and High Growth Companies).

Involved fees earner: Chad Bayne – Osler Hoskin & Harcourt; Jennifer Humphrey – Osler Hoskin & Harcourt; Janice To – Osler Hoskin & Harcourt;

Law Firms: Osler Hoskin & Harcourt;

Clients: Chinova Bioworks;

Sonia Carcano

Author: Sonia Carcano